Skip to main content
. 2022 Feb 21;94(9):3888–3896. doi: 10.1021/acs.analchem.1c04870

Figure 2.

Figure 2

cIMS separation of a synthetic mixture of trastuzumab heavy chain peptide W99-K124 with Asp and isoAsp at position 102 (i.e., the fourth residue in the peptide sequence). Mass spectrum insets show the z23 ions observed for each mobility peak. The presence of z23–57 ions confirmed the mobility peak at 26 ms is the peptide containing isoAsp.